These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28054978)

  • 1. Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?
    Alayash AI
    Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28054978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: clinical safety and efficacy of recent and current products.
    Jahr JS; Akha AS; Holtby RJ
    Curr Drug Discov Technol; 2012 Sep; 9(3):158-65. PubMed ID: 21745179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative pathways in the sickle cell and beyond.
    Alayash AI
    Blood Cells Mol Dis; 2018 May; 70():78-86. PubMed ID: 28554826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
    Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
    J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood substitutes and oxygen therapeutics: an overview and current status.
    Jahr JS; Nesargi SB; Lewis K; Johnson C
    Am J Ther; 2002; 9(5):437-43. PubMed ID: 12237737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All hemoglobin-based oxygen carriers are not created equally.
    Buehler PW; Alayash AI
    Biochim Biophys Acta; 2008 Oct; 1784(10):1378-81. PubMed ID: 18206989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Biochemical and Biophysical Characterization of Hemoglobin-Based Oxygen Carrier Therapeutics: All HBOCs Are Not Created Equally.
    Meng F; Kassa T; Jana S; Wood F; Zhang X; Jia Y; D'Agnillo F; Alayash AI
    Bioconjug Chem; 2018 May; 29(5):1560-1575. PubMed ID: 29570272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design.
    Buehler PW; D'Agnillo F; Schaer DJ
    Trends Mol Med; 2010 Oct; 16(10):447-57. PubMed ID: 20708968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the blood substitute HBOC-201 in critically ill patients during sickle crisis: a three-case series.
    Davis JM; El-Haj N; Shah NN; Schwartz G; Block M; Wall J; Tidswell M; DiNino E
    Transfusion; 2018 Jan; 58(1):132-137. PubMed ID: 29076161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin-Based Oxygen Carrier (HBOC) Development in Trauma: Previous Regulatory Challenges, Lessons Learned, and a Path Forward.
    Keipert PE
    Adv Exp Med Biol; 2017; 977():343-350. PubMed ID: 28685464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From hemoglobin allostery to hemoglobin-based oxygen carriers.
    Faggiano S; Ronda L; Bruno S; Abbruzzetti S; Viappiani C; Bettati S; Mozzarelli A
    Mol Aspects Med; 2022 Apr; 84():101050. PubMed ID: 34776270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/II study of polymerized bovine hemoglobin in adult patients with sickle cell disease not in crisis at the time of study.
    Gonzalez P; Hackney AC; Jones S; Strayhorn D; Hoffman EB; Hughes G; Jacobs EE; Orringer EP
    J Investig Med; 1997 Jun; 45(5):258-64. PubMed ID: 9249998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBOC-201, hemoglobin glutamer-250 (bovine), Hemopure (Biopure Corporation).
    Jahr JS; Moallempour M; Lim JC
    Expert Opin Biol Ther; 2008 Sep; 8(9):1425-33. PubMed ID: 18694360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial oxygen carrier with pharmacologic actions of adenosine-5'-triphosphate, adenosine, and reduced glutathione formulated to treat an array of medical conditions.
    Simoni J; Simoni G; Moeller JF; Feola M; Wesson DE
    Artif Organs; 2014 Aug; 38(8):684-90. PubMed ID: 24980041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High- and low-affinity PEGylated hemoglobin-based oxygen carriers: Differential oxidative stress in a Guinea pig transfusion model.
    Alomari E; Ronda L; Bruno S; Paredi G; Marchetti M; Bettati S; Olivari D; Fumagalli F; Novelli D; Ristagno G; Latini R; Cooper CE; Reeder BJ; Mozzarelli A
    Free Radic Biol Med; 2018 Aug; 124():299-310. PubMed ID: 29920341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SANGUINATE (PEGylated Carboxyhemoglobin Bovine): Mechanism of Action and Clinical Update.
    Abuchowski A
    Artif Organs; 2017 Apr; 41(4):346-350. PubMed ID: 28397407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin substitutes.
    Anbari KK; Garino JP; Mackenzie CF
    Eur Spine J; 2004 Oct; 13 Suppl 1(Suppl 1):S76-82. PubMed ID: 15168238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoglobin-based oxygen carriers for hemorrhagic shock.
    Elmer J; Alam HB; Wilcox SR
    Resuscitation; 2012 Mar; 83(3):285-92. PubMed ID: 21978876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential uses of hemoglobin-based oxygen carriers in critical care medicine.
    Creteur J; Vincent JL
    Crit Care Clin; 2009 Apr; 25(2):311-24, Table of Contents. PubMed ID: 19341911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemoglobin-based oxygen carriers and trials to substitute red blood cells].
    Smani Y; Labrude P; Vigneron C; Faivre B
    Transfus Clin Biol; 2007 Nov; 14(5):464-73. PubMed ID: 18295525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.